Effective Treatments for Japanese Patients' Skin Lesions Associated with Discoid Lupus Erythematosus | Chapter 6 | Advanced Concepts in Pharmaceutical Research Vol. 3

 This branch aims to discuss about Effective Situations for Japanese Sufferers' Skin Lesions Associated with Discoid lupus erythematosus (DLE). DLE is an instigative skin disease that can occur in subjects with or outside systemic lupus erythematosus (SLE). Localized DLE, statement/widespread DLE, hypertrophic/ verrucous DLE, and mucosal DLE are all dispassionate characteristics. There are current and systemic therapies convenient. Corticosteroids and calcineurin inhibitors are examples of local treatments.  Antimalarials are widely accepted as first-line fundamental therapy around the planet. Dapsone and/or retinoids can also be advantageous if the positive and negative effects are cautiously considered. It is detracting to understand and explore the procedures of skin eruption development appropriating various methods such as mouse models so that find better treatments.This publication interprets the characteristics of DLE, allure pathogenesis, diagnostics, and current and novel targeted analysis. A PubMed and Cochrane Database of Systemic Reviews article search was conducted, and ultimate relevant references were deliberate. DLE treatment surrounds both topical and intrinsic treatments. Professional application of local corticosteroids and calcineurin inhibitors is considered first-line healing. When topical treatments are useless, antimalarials are accepted as a first-line systemic analysis.  An immunosuppressive or immunomodulator may be additional if the antimalarial treatment program is insufficient. Few novel promising medicines have existed evaluated or proven in patients who have enhance resistant to miscellaneous combinations of antimalarials and immunosuppressives/immunomodulators.

Author(s) Details:

Fukumi Furukawa,
Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, 641-8509 Wakayama, Japan.

Please see the link here: https://stm.bookpi.org/ACPR-V3/article/view/12699

A Brief Study of Nigella sativa (Kalonji): A Unique Immunomodulator of Unani Medicine | Chapter 12 | Issues and Developments in Medicine and Medical Research Vol. 4

 Throughout its thousands of years of practise, the Unani System of Medicine has accumulated a wealth of medical knowledge. Herbal medications are becoming increasingly important in modern science, as new scientific information on their safety and usefulness emerges on a regular basis. The pandemic of COVID-19 has emphasised the urgent need for immunomodulators, as inadequate immune modulation is one of the elements that contributes to the disease's aetiology and leads to poor outcomes in COVID-19 patients. Innovative methods and extensive research on immunomodulatory natural products, plants, and their extracts are being pursued in order to generate a novel immunomodulatory agent to complement current chemotherapies. Kalonji (Nigella sativa Linn) has risen to the top of the evidence-based herbal medicine rankings. It has been discovered that Thymoquine, the principal bioactive component of Kalonji's essential oil, is responsible for the majority of the plant's therapeutic benefits. Even on COVID-19, many investigations have shown that N. sativa is a strong immunomodulator and antiviral drug. To highlight the notion of Manaat (Immunity) in the Unani System of Medicine, this article attempts to describe recent scientific work carried out by modern scientists on immunomodulator actions of the most renowned Unani single drug-Kalonji seeds. This will aid in the development of a powerful immunomodulator to tackle the horrors of the COVID-19 pandemic in the near future. In this direction, we can incorporate the complete Kalonji seed or Raughan Kalonji for future comparison studies with Thymoquine on immunomodulation and antiviral studies, as per Unani medicine's concept.

Author(S) Details

Zehra Zaidi
Department of Ain, Uzun, Anaf WA Halaq, School of Unani Medical Education & Research, Jamia Hamdard, New Delhi, India.

View Book:- https://stm.bookpi.org/IDMMR-V4/article/view/5549